Samsung gets FDA approval – takes leap into US OTC market
Samsung gets FDA approval – takes leap into US OTC market medwatch.com
Regulatory Approvals
US FDA approves Bristol Myers’ blood cancer treatment
US FDA approves Bristol Myers' blood cancer treatment Reuters
FDA Approves Iberdomide Combo in Relapsed/Refractory Multiple Myeloma
FDA Approves Iberdomide Combo in Relapsed/Refractory Multiple Myeloma CancerNetwork
FDA Approves Novel Iberdomide Regimen in RRMM
FDA Approves Novel Iberdomide Regimen in RRMM The American Journal of Managed Care
Dr Banerjee on the FDA Approval of Iberdomide Plus Daratumumab/Dexamethasone in R/R Myeloma
Dr Banerjee on the FDA Approval of Iberdomide Plus Daratumumab/Dexamethasone in R/R Myeloma OncLive